Search results for " transplantation"

showing 10 items of 1513 documents

PTFE mesh in renal allograft compartment syndrome.

2006

We report a case of anuria in a 42-year-old female kidney transplant patient that occurred secondary to extrinsic compression from a large kidney being placed extraperitoneally in a small iliac fossa. Prompt reexploration in the immediate postoperative period resulted in salvage of the graft with restoration of kidney function. The abdominal wall was reconstructed using prosthetic mesh, which decreased the compartment pressure within the iliac fossa sufficiently to allow the renal vein patency and the kidney perfusion. We think that this tension-free surgical technique should be applied in those cases in which the retroperitoneal space is less than the size of the kidney to avoid renal allo…

AdultMalemedicine.medical_specialtyIncisional herniaIliac fossaAnuriaCompartment SyndromesRenal DialysismedicineRetroperitoneal spaceHumansTransplantation HomologousPolytetrafluoroethyleneKidney transplantationTransplantationKidneybusiness.industrySurgical Meshmedicine.diseaseKidney TransplantationSurgerymedicine.anatomical_structureSurgical meshSurgeryAnuriaRenal veinmedicine.symptombusinessTransplantation proceedings
researchProduct

Intrahepatic biliary anatomy derived from right graft adult live donor liver transplantation

2008

Abstract Objective The successful management of the bile duct in right graft adult live donor liver transplantation requires knowledge of both its central (hilar) and distal (sectorial) anatomy. The purpose of this study was to provide a systematic classification of its branching patterns to enhance clinical decision-making. Patients and Methods We analyzed three-dimensional computed tomography (3-D CT) imaging reconstructions of 139 potential live liver donors evaluated at our institution between January 2003 and June 2007. Results Fifty-four (n = 54 or 38.8%) donor candidates had a normal (classic) hilar and sectorial right bile duct anatomy (type I). Seventy-eight (n = 78 or 56.1%) cases…

AdultMalemedicine.medical_specialtyLive donormedicine.medical_treatmentCholecystographyHepatic Duct CommonLiver transplantationliverImage Processing Computer-AssistedLiving DonorsmedicineHumansRetrospective StudiesTransplantationmedicine.diagnostic_testBile ductbusiness.industryGallbladderGallbladderRetrospective cohort studyMiddle AgedCholecystographyLiver TransplantationSurgeryBiliary anatomymedicine.anatomical_structureBiliary tractFemaleSurgeryTomography X-Ray Computedbusiness
researchProduct

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

2014

This is the first prospective study of deferasirox in adult allogeneic hematopoietic stem cell transplant recipients with transfusional iron overload in hematologic malignancies. Patients at least six months post transplant were treated with deferasirox at a starting dose of 10 mg/kg/day for 52 weeks or until serum ferritin was less than 400 ng/mL on two consecutive occasions. Thirty patients were enrolled and 22 completed the study. A significant reduction from baseline in median serum ferritin and in liver iron concentration at 52 weeks was observed in the overall population: from 1440 to 755.5 ng/mL (P=0.002) and from 14.5 to 4.6 mg Fe/g dw (P=0.0007), respectively. Reduction in serum fe…

AdultMalemedicine.medical_specialtyLiver Iron ConcentrationIron Overloadmedicine.medical_treatmentPopulationStem cellsHematopoietic stem cell transplantationIron Chelating AgentsBenzoatesGastroenterologyYoung Adultchemistry.chemical_compoundInternal medicinemedicineHumansTransplantation HomologousAdverse effecteducationProspective cohort studyAgededucation.field_of_studyCreatininebusiness.industryDeferasiroxHematopoietic Stem Cell TransplantationHematologic diseasesTransfusion ReactionArticlesHematologyMiddle AgedTriazolesSurgeryTransplantationDeferasiroxTreatment OutcomechemistryMalalties hematològiquesFerritinsFemaleCèl·lules marebusinessmedicine.drug
researchProduct

MRI in lung transplant recipients using hyperpolarized 3He: comparison with CT.

2002

PURPOSE To elucidate the ability of 3He-MRI to detect ventilation defects in lung transplant recipients, 3He-MRI was compared to CT for concordance. MATERIALS AND METHODS We examined 14 lung recipients using 3He-MRI on a 1.5 T MR scanner. CT served as a reference method. Up to four representative ventilation defects were defined for each lung on 3He-MRI and compared to corresponding areas on CT. RESULTS Altogether, 59 representative ventilation defects were defined on 3He-MRI. Plausible CT correlates were found for 29 ventilation defects; less plausible CT correlates were found for eight defects. In 22 defects (37%) no corresponding CT changes were detected. CT demonstrated correlates for v…

AdultMalemedicine.medical_specialtyLungbusiness.industryConcordanceEarly detectionBronchiolitis obliteransMiddle Agedmedicine.diseaseHeliumMagnetic Resonance ImagingSensitivity and Specificitymedicine.anatomical_structuremedicineBreathingHumansRadiology Nuclear Medicine and imagingFemaleRadiologybusinessPulmonary VentilationTomography X-Ray ComputedLungLung TransplantationJournal of magnetic resonance imaging : JMRI
researchProduct

Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains i…

2009

In the past 20 years, management of primary myelofibrosis (PMF) has incorporated new treatment approaches, but survival benefits have not been confirmed in controlled studies. This retrospective study includes 176 consecutive patients younger than age 60 years in whom PMF was diagnosed during a 30-year period (1976-2005). Median age at diagnosis was 50 years (range, 18-59 years), and 98 patients (55%) were men. At the time of this report, 99 patients (56%) had died; the 77 surviving patients were followed up for a median of 8 years (range, 4-24 years). Overall median survival was 9.2 years, and 15- and 20-year survival rates were 32% and 20%, respectively. According to the Dupriez Prognosti…

AdultMalemedicine.medical_specialtyMultivariate analysisTransplantation ConditioningAdolescentmedicine.medical_treatmentDiseaseHematopoietic stem cell transplantationKaplan-Meier EstimateDisease-Free SurvivalSettore MED/15 - Malattie Del Sanguemyelofibrosis survivalSurvival dataInternal medicinemedicineHumansMyelofibrosisSurvival rateProportional Hazards ModelsRetrospective Studiesbusiness.industryProportional hazards modelBrief ReportHematopoietic Stem Cell TransplantationRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyUnited StatesSurgerySurvival RatePrimary MyelofibrosisMultivariate AnalysisFemalebusiness
researchProduct

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fl…

2005

The safety and efficacy of early bacterial prophylaxis with piperacillin-tazobactam were prospectively evaluated in 51 autologous peripheral blood stem cell transplantation (PBSCT) recipients. The results were compared with those obtained in 51 control patients receiving oral fluoroquinolones in a retrospective matched-pair control study. Overall, 76% of the study group and 98% of the control group developed at least one febrile episode during neutropenia (P=0.002). Time from neutropenia to the first febrile episode (FFE) was significantly longer in the study group than in the control group (P=0.04). Once a febrile episode appeared, the duration of fever was significantly longer in cases th…

AdultMalemedicine.medical_specialtyNeutropeniaAdolescentFevermedicine.drug_classMatched-Pair AnalysisPremedicationAntibioticsPenicillanic AcidBacteremiaGram-Positive BacteriaTazobactamTransplantation AutologousInternal medicineAmphotericin BGram-Negative Bacteriapolycyclic compoundsmedicineHumansAntibacterial agentAgedPiperacillinTransplantationPeripheral Blood Stem Cell TransplantationHematologybusiness.industryHematologyBacterial InfectionsMiddle AgedSurgeryPiperacillin Tazobactam Drug CombinationPiperacillin/tazobactamChemoprophylaxisFemaleStem cellbusinessPiperacillinmedicine.drugFluoroquinolonesBone marrow transplantation
researchProduct

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

1997

Type, severity and incidence of infection during the neutropenic period after peripheral blood stem cell transplantation (PBSCT) for treatment of malignant disease were studied in 66 patients treated at a single institution. Data of 34 female and 32 male patients with a median age of 43 years suffering from leukemia (12), lymphoma (35), multiple myeloma (six) or solid tumors (13) were retrospectively analyzed. All patients had received at least 2.5 x 10(6) CD34-positive cells for stem cell rescue after high-dose chemotherapy. Ninety-four percent of the patients experienced at least one febrile episode during their post-transplant course. The patients recovered quickly and defervesced after …

AdultMalemedicine.medical_specialtyNeutropeniaAdolescentmedicine.medical_treatmentNeutropeniaCommunicable DiseasesAnti-Infective AgentsNeoplasmsInternal medicineHumansMedicineMultiple myelomaRetrospective StudiesTransplantationChemotherapyLeukopeniabusiness.industryIncidence (epidemiology)Hematopoietic Stem Cell TransplantationHematologyMiddle Agedmedicine.diseaseSurgeryLeukemiaBacteremiaFemalemedicine.symptomStem cellbusinessBone Marrow Transplantation
researchProduct

Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patie…

1998

Extensive pretreatment has been identified as a significant risk factor for failure of sufficient PBSC mobilization. From published data and our own experience we defined pretreatment variables which render patients at risk for not collecting at least 2.5 x 10(6) CD34-positive cells per kg bodyweight (BW). These variables were previous unsuccessful PBSC mobilization trial, previous large field radiotherapy, four or more cycles of myelosuppressive chemotherapy regimens, and combinations of extended field radiotherapy plus chemotherapy. Based on these inclusion criteria we treated 19 patients with disease-specific conventional-dose chemotherapy followed by sequential subcutaneous administrati…

AdultMalemedicine.medical_specialtyNeutropeniaFevermedicine.medical_treatmentPainSalvage therapyGastroenterologyTesticular NeoplasmsRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansMultiple myelomaTesticular cancerSalvage TherapyTransplantationMyelosuppressive ChemotherapyChemotherapybusiness.industryRemission InductionHematopoietic Stem Cell TransplantationDrug SynergismHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyHematopoietic Stem Cell MobilizationBlood Cell CountSeminomaSurgeryGranulocyte colony-stimulating factorLymphomaRegimenHematologic NeoplasmsFemaleInterleukin-3GerminomabusinessBone Marrow Transplantation
researchProduct

Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation

2019

The replication kinetics of nonpathogenic anelloviruses belonging to the Alphatorquevirus genus (such as torque teno virus) might reflect the overall state of posttransplant immunosuppression. We analyzed 221 kidney transplant (KT) recipients in whom plasma alphatorquevirus DNA load was quantified by real-time polymerase chain reaction at baseline and regularly through the first 12 posttransplant months. Study outcomes included posttransplant infection and a composite of opportunistic infection and/or de novo malignancy (immunosuppression-related adverse event [iRAE]). Alphatorquevirus DNA loads at month 1 were higher among patients who subsequently developed posttransplant infection (P  = …

AdultMalemedicine.medical_specialtyOpportunistic infectionmedicine.medical_treatment030230 surgeryAnelloviridaeGastroenterologylaw.invention03 medical and health sciences0302 clinical medicinelawInternal medicinemedicineHumansImmunology and AllergyPharmacology (medical)Prospective StudiesAdverse effectPolymerase chain reactionKidney transplantationAgedTransplantationbusiness.industryHazard ratioImmunosuppressionMiddle Agedmedicine.diseaseKidney TransplantationConfidence intervalDNA ViralFemalebusinessViral loadImmunosuppressive AgentsAmerican Journal of Transplantation
researchProduct

Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.

2011

Background. Liver transplantation (LT) has been accepted as a treatment in selected cases of neuroendocrine tumors (NETs) with hepatic metastases. Patients and Methods. A systematic review of the literature was conducted to evaluate long-term patient survival in the instances of LT for pancreatic NET. Univariate and multivariate regression analyses and survival analysis were performed. Results. Fifty-three clinical studies were screened. Data from 20 studies encompassing 89 transplanted patients were included in the study. Most primary tumors were endocrine pancreatic tumors (n = 69), with gastrinomas representing the most frequent diagnosis (n = 21). There were 61 functioning pancreatic NE…

AdultMalemedicine.medical_specialtyPancreatic diseaseAdolescentmedicine.medical_treatmentPopulationMedizinLiver transplantationNeuroendocrine tumorsGastroenterologyYoung AdultPancreatic tumorInternal medicineCarcinomamedicineHumanseducationChildSurvival analysisRetrospective StudiesTransplantationeducation.field_of_studybusiness.industryLiver NeoplasmsCancerMiddle Agedmedicine.diseasePrognosisSurvival AnalysisCarcinoma NeuroendocrineLiver TransplantationPancreatic NeoplasmsFemalebusinessTransplantation
researchProduct